Clinical Trial Update: Rituximab in Interstitial Pneumonitis [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports completion of Phase 2 and Phase 3 studies evaluating rituximab for interstitial pneumonitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Pneumonitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Human Adams | Conditions: Lung Diseases, Interstitial, Pneumonitis, Interstitial | Phase 2, Phase 3 | Status: COMPLETED